CRISPR activation of long non-coding RNA DANCR promotes bone regeneration

• Published in: Biomaterials Vol. 275; p. 120965
• Main Authors: Nguyen, Nuong Thi Kieu, Chang, Yu-Han, Truong, Vu Anh, Hsu, Mu-Nung, Pham, Nam Ngoc, Chang, Chin-Wei, Wu, Yi-Hsiu, Chang, Yi-Hao, Li, Hung, Hu, Yu-Chen
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.08.2021
• Subjects: Animals; Bone healing; Bone Regeneration; Cell Differentiation; Chondrogenesis; CRISPR-Cas Systems; CRISPRa; DANCR; dCas9-VPR; lncRNA; miRNA; Rats; RNA, Guide, CRISPR-Cas Systems; RNA, Long Noncoding; miRNA; lncRNA; Bone healing; CRISPRa; DANCR; dCas9-VPR
• ISSN: 0142-9612; 1878-5905
• DOI: 10.1016/j.biomaterials.2021.120965

Healing of large calvarial bone defects in adults adopts intramembranous pathway and is difficult. Implantation of adipose-derived stem cells (ASC) that differentiate towards chondrogenic lineage can switch the bone repair pathway and improve calvarial bone healing. Long non-coding RNA DANCR was recently uncovered to promote chondrogenesis, but its roles in rat ASC (rASC) chondrogenesis and bone healing stimulation have yet to be explored. Here we first verified that DANCR expression promoted rASC chondrogenesis, thus we harnessed CRISPR activation (CRISPRa) technology to upregulate endogenous DANCR, stimulate rASC chondrogenesis and improve calvarial bone healing in rats. We generated 4 different dCas9-VPR orthologues by fusing a tripartite transcription activator domain VPR to catalytically dead Cas9 (dCas9) derived from 4 different bacteria, and compared the degree of activation using the 4 different dCas9-VPR. We unveiled surprisingly that the most commonly used dCas9-VPR derived from Streptococcus pyogenes barely activated DANCR. Nonetheless dCas9-VPR from Staphylococcus aureus (SadCas9-VPR) triggered efficient activation of DANCR in rASC. Delivery of SadCas9-VPR and the associated guide RNA into rASC substantially enhanced chondrogenic differentiation of rASC and augmented cartilage formation in vitro. Implantation of the engineered rASC remarkably potentiated the calvarial bone healing in rats. Furthermore, we identified that DANCR improved the rASC chondrogenesis through inhibition of miR-203a and miR-214. These results collectively proved that DANCR activation by SadCas9-VPR-based CRISPRa provides a novel therapeutic approach to improving calvarial bone healing. [Display omitted]